{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:10:42Z","timestamp":1763705442269,"version":"3.40.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jns.2018.05.001","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T05:29:47Z","timestamp":1525325387000},"page":"212-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Ticagrelor for stroke prevention in patients with vascular risk factors: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"390","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5383-8101","authenticated-orcid":false,"given":"Konark","family":"Malhotra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alissa S.","family":"Kasunich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil A.","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristeidis H.","family":"Katsanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei V.","family":"Alexandrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Tsivgoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jns.2018.05.001_bb0005","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.jns.2018.05.001_bb0010","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jns.2018.05.001_bb0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus Clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jns.2018.05.001_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1603060","article-title":"Ticagrelor versus aspirin in acute stroke or transient ischemic attack","volume":"375","author":"Johnston","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jns.2018.05.001_bb0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1474-4422(17)30038-8","article-title":"Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial","volume":"16","author":"Amarenco","year":"2017","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jns.2018.05.001_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with aspirin in acute minor stroke or transient ischemic attack","volume":"369","author":"Wang","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"9431","key":"10.1016\/j.jns.2018.05.001_bb0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.jns.2018.05.001_bb0040","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/CIRCULATIONAHA.109.895342","volume":"121","author":"Berger","year":"2010","journal-title":"Circulation"},{"issue":"10093","key":"10.1016\/j.jns.2018.05.001_bb0045","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(17)30770-5","article-title":"Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study","volume":"390","author":"Li","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.jns.2018.05.001_bb5000","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/STROKEAHA.117.019166","article-title":"Cerebrovascular outcomes with proton pump inhibitors and thienopyridines: a systematic review and meta-analysis","volume":"49","author":"Malhotra","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2018.05.001_bb0050","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ (Clin. Res. ed.)"},{"key":"10.1016\/j.jns.2018.05.001_bb0055","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clin. Res. ed.)"},{"year":"2011","author":"Higgins","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","key":"10.1016\/j.jns.2018.05.001_bb0060"},{"key":"10.1016\/j.jns.2018.05.001_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ (Clinical Res. Ed.)"},{"issue":"19","key":"10.1016\/j.jns.2018.05.001_bb0070","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2007.07.053","volume":"50","author":"Cannon","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.jns.2018.05.001_bb0075","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1253\/circj.CJ-15-0112","article-title":"Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome \u2014 randomized, double-blind, phase III PHILO study","volume":"79","author":"Goto","year":"2015","journal-title":"Circ. J."},{"issue":"21","key":"10.1016\/j.jns.2018.05.001_bb0080","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/CIRCULATIONAHA.116.024823","article-title":"Prasugrel versus Ticagrelor in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: multicenter randomized PRAGUE-18 study","volume":"134","author":"Motovska","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jns.2018.05.001_bb0085","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/FJC.0000000000000390","article-title":"Assessment of Ticagrelor versus Clopidogrel treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"68","author":"Tang","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jns.2018.05.001_bb0090","series-title":"Efficacy and Safety Outcomes of Ticagrelor Compared with Clopidogrel in Elderly Chinese Patients with Acute Coronary Syndrome, Therapeutics and clinical risk management 12","first-page":"1101","author":"Wang","year":"2016"},{"issue":"6","key":"10.1016\/j.jns.2018.05.001_bb0095","first-page":"11831","article-title":"Safety and efficacy of ticagrelor with emergency percutaneous coronary intervention in senile patients with ST-segment elevation myocardial infarction and dementia","volume":"9","author":"Wang","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.jns.2018.05.001_bb0100","series-title":"International Stroke Conference 2018 (Podium Presentation)","article-title":"Ticagrelor with Aspirin on Platelet Reactivity in Minor stroke or Transient Ischemic Attack (PRINCE) trial: final Analysis","author":"Wang","year":"2018"},{"issue":"3","key":"10.1016\/j.jns.2018.05.001_bb0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/AC.71.3.3152091","article-title":"High-dose clopidogrel versus ticagrelor for treatment of acute coronary syndromes after percutaneous coronary intervention in CYP2C19 intermediate or poor metabolizers: a prospective, randomized, open-label, single-Centre trial","volume":"71","author":"Zhang","year":"2016","journal-title":"Acta Cardiol."},{"issue":"3","key":"10.1016\/j.jns.2018.05.001_bb0110","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.amjcard.2015.04.050","article-title":"Comparison of Ticagrelor versus Prasugrel to prevent Periprocedural Myonecrosis in acute coronary syndromes","volume":"116","author":"Bonello","year":"2015","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"10.1016\/j.jns.2018.05.001_bb0115","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"23","key":"10.1016\/j.jns.2018.05.001_bb0120","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.jacc.2014.03.031","article-title":"Adenosine-mediated effects of ticagrelor: evidence and potential clinical relevance","volume":"63","author":"Cattaneo","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.jns.2018.05.001_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12205-w","article-title":"Effects of ticagrelor in a mouse model of ischemic stroke","volume":"7","author":"Yamauchi","year":"2017","journal-title":"Sci. Rep."},{"issue":"7347","key":"10.1016\/j.jns.2018.05.001_bb0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jns.2018.05.001_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11883-017-0677-7","article-title":"Internal carotid artery occlusion: pathophysiology, diagnosis, and management","volume":"19","author":"Malhotra","year":"2017","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"10.1016\/j.jns.2018.05.001_bb0140","doi-asserted-by":"crossref","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 guidelines for the early Management of Patients with Acute Ischemic Stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.jns.2018.05.001_bb0145","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/CIRCULATIONAHA.109.919456","article-title":"Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study","volume":"121","author":"Gurbel","year":"2010","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jns.2018.05.001_bb0150","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jcin.2016.02.039","article-title":"Pharmacodynamic effects of switching from Prasugrel to Ticagrelor: results of the prospective, randomized SWAP-3 study","volume":"9","author":"Franchi","year":"2016","journal-title":"JACC. Cardiovascb Intervent."},{"year":"2017","author":"Valgimigli","key":"10.1016\/j.jns.2018.05.001_bb0155"},{"issue":"2","key":"10.1016\/j.jns.2018.05.001_bb0160","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.carrev.2016.10.005","article-title":"A comparison of cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention: a network meta-analysis","volume":"18","author":"Westman","year":"2017","journal-title":"Cardiovasc. Revascularization Med."},{"key":"10.1016\/j.jns.2018.05.001_bb0165","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ (Clin. Res. ed.)"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18302156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18302156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T21:58:15Z","timestamp":1534888695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18302156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":34,"alternative-id":["S0022510X18302156"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.05.001","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ticagrelor for stroke prevention in patients with vascular risk factors: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}